Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-12

Clinical Trial Update: Honey & Nigella Sativa Trial Against COVID-19 [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating honey and Nigella sativa for coronavirus infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Honey & Nigella Sativa

Snippet

Sponsor: Sohaib Ashraf | Conditions: Coronavirus Infection, Sars-CoV2 | Phase 3 | Status: COMPLETED